He mea hou ʻo Dihexa oligopeptides ʻO ka peptide bioactive i hoʻolālā ʻia no ka mālama ʻana o nā maʻi neurodegenerative.
Ua hōʻike mua ʻia ma 2012, ua hoʻomaka ʻia mai ka ʻimi ʻana a me ka ʻenekini huli hope o angiotensin IVNā hopena i nā ala hōʻailona o ka lolo endogenous.
Hoʻonui ka hoʻolālā molekula non-natural o Dihexa i ke koho kikoʻī kikoʻī o ke kelepona i nā wahi i hoʻopaʻa ʻia; Ua kākau ʻia nā hoʻomaikaʻi koʻikoʻi o ka metabolic stability, ʻO ka bioavailability waha ikaika a me ke komo ʻana o ka ʻōnaehana kikowaena kiʻekiʻe ʻo ia ʻelua o kāna mau hiʻohiʻona kaulana.
Ke lawelawe nei ma ke ʻano he mea hana maikaʻi loa a ikaika c-Met receptor agonist, nā ʻano āpau o ka hoʻomohala ʻana i ka ʻōnaehana kikowaena, hoʻoponopono a hiki i ka nui o ka hana hou, ua maʻalahi ʻia e ia.
Kaʻina
Hexanoyl-Tyr-Ile-Ahx-NH2
Helu CAS
1401708-83-5
ʻĀpana Molekala
C27H44N4O5
Kaumaha Molekala
504.67
Noi'i o Dihexa Peptide
1.ʻO ka hiki ke hoʻomaʻamaʻa a me ka hana o ka hana
ʻO ka hoʻomaikaʻi ʻana i ke aʻo ʻana a me ka hoʻomanaʻo ʻana kekahi o nā hopena maikaʻi i ʻike pololei ʻia.
ʻO ka pōʻino neuronal mai nā kumu he nui – kaumaha oxidative, β-amyloid (Aβ) ʻona pili, ka hana ʻole o ka mitochondrial – hiki ke kāohi ʻia e Dihexa.
Nā noi kumu no ka mālama ʻana i kahi ākea o nā maʻi neurological degenerative (ʻO Alzheimer, ʻo Parkinson, ʻO Huntington nā hiʻohiʻona nui) hahai mai keia laina o ka noii.
Oligodendrocyte precursor cell ʻokoʻa, hana hou pili i ka myelin, ʻO ka hoʻomaikaʻi ʻana o ke kahe koko cerebral / hāʻawi ʻana i ka ikehu a i kekahi pae ke kākoʻo ʻia nā hopena anti-tumour e nā hōʻike o kēia manawa.
Loaʻa ka mana nui no Dihexa ma ke ʻano he lāʻau lapaʻau.
2.Hoʻonui i ke aʻo ʻana a me ka hoʻomanaʻo
ʻO ka ʻōnaehana HGF/CMet He kumu nui ia i ka hoʻoulu ʻana i ka hippocampal.
Ma kahi hoʻokolohua maze, ua hōʻike ka pūʻulu Dihexa i ka hiki ke aʻo ikaika; ʻimi i nā paepae huna, ua hana lākou pēlā i nā manawa pōkole loa ma mua o ka hui hoʻomalu.
ʻO ka HGF-Tg ʻO ka hui ponoʻī i hōʻike i ka pololei kiʻekiʻe a me ka hoʻoikaika ʻana i ke aʻo ʻana.
Hoʻohālikelike ʻia me ka mana ʻano hihiu, ʻO ka hoʻonui ʻia ʻana o ka HGF i alakaʻi ʻia i kahi piʻi aʻe o nā cell receptor hippocampal kikoʻī – ʻO ka hoʻonui ʻana i ke aʻo ʻana a me ka hoʻomanaʻo ʻana kekahi o nā hopena maikaʻi pololei i ʻike ʻia.
3.Hoʻolaha i ka Synapsis a me ka Dendrite Formation
Me he mea ulu hepatocyte (HGF)/c-Met receptor agonist, Hoʻoulu ʻo Dihexa i nā ala hōʻailona like ʻole (PI3K/Act ka mea mua, MAPK/ERK lua), hoʻomaʻamaʻa pololei i nā mea hou synapse a i ka nui loa dendrite ka hoʻokumu ʻana i loko o nā neurons.
ʻO ka poho Dendrite ke kumu kumu mua o nā ʻano like ʻole o ka hoʻomanaʻo mau ʻana; ʻo ka pilikia o ke aʻo ʻana e hahai pono ana ma hope.
Hōʻike nā hoʻokolohua holoholona iā Dihexa i loaʻa i ka hiki ke hoʻōla maoli no nā maʻi kūikawā o Alzheimer.
4.Neuroprotection a me Anti-apoptosis
Ke holomua nei nā maʻi neurodegenerative ma o nā ala he nui – kaumaha oxidative, nā ʻano like ʻole o ka mitochondrial dysfunction, a me ka hopena hope o ka abnormal hoʻohui pūmua e alakaʻi ana i ka neuronal apoptosis.
Dihexa, ma ka hoʻoulu ʻana i ka ʻōnaehana HGF i ʻōlelo ʻia, hoʻopau pono i kēia kaʻina hana; kaohi ana (a lohi paha) ʻO ka lawe piha ʻana i nā hōʻailona apoptotic he ʻāpana koʻikoʻi o kāna hana neuroprotective.
5.Hoʻoikaika i ka hana hou ʻana o ka myelin
ʻO Myelin kēlā puʻu momona e uhi ana i ka axon o kahi neuron, pololei a wikiwiki hoʻi ka hoʻouna ʻana i ka hōʻailona nerve ma muli o ia.
ʻO nā maʻi nele o Myelin e alakaʻi i nā ʻano neurological dysfunctions.
Oligodendrocyte precursor cell (a i kahi lae, nā pūnaewele neural a pau) hiki ke hoʻoulu ʻia e hoʻoikaika i ka hoʻōla hou ʻana o ka myelin, a he hopena maopopo a maikaʻi hoʻi ʻo Dihexa i ka ʻōnaehana nerve holoʻokoʻa.
COA
HPLC
MS





